PFIZER, INC. |
Market Closed -
Other stock markets
|
Pre-market 07:05:01 pm | |||
| 28.8 USD | -2.54% |
|
28.86 | +0.19% |
| Jun. 05 | Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment | DJ |
| Jun. 05 | Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment | MT |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.89% | 121 M€ | +8.99% | - | |
| 0.88% | 204 M€ | +10.54% | ||
| 0.85% | 8 M€ | +6.85% | - | |
| 0.85% | 744 M€ | +10.13% | ||
| 0.84% | 9 M€ | +10.29% | ||
| 0.82% | 104 M€ | +10.63% | ||
| 0.78% | 265 M€ | +4.29% | - | |
| 0.75% | 1 M€ | +0.04% | ||
| 0.75% | 559 M€ | +14.30% | ||
| 0.75% | 1,848 M€ | +18.39% | - | |
| 0.72% | 2,517 M€ | +13.83% | - | |
| 0.70% | 57 M€ | +23.31% | - | |
| 0.65% | 8 M€ | +5.48% | - | |
| 0.63% | 7 M€ | +9.14% | - | |
| 0.60% | 283 M€ | +21.68% | ||
| 0.60% | 50 M€ | +12.54% | ||
| 0.60% | 273 M€ | -.--% | ||
| 0.60% | 1,174 M€ | +23.54% | ||
| 0.60% | 655 M€ | -.--% | - | |
| 0.59% | 22 M€ | +14.45% | ||
| 0.54% | 414 M€ | +12.87% | - | |
| 0.54% | 1,006 M€ | -.--% | - | |
| 0.54% | 3 M€ | +15.16% | - | |
| 0.54% | 13 M€ | -.--% | - | |
| 0.54% | 4 M€ | -.--% | - | |
| 0.52% | 1 M€ | -.--% | ||
| 0.52% | 284 M€ | -.--% | ||
| 0.51% | 29 M€ | -.--% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
2024-06-10
- Goldman Sachs Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.8
USD
Average target price
31.92
USD
Spread / Average Target
+10.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.03% | 167B | |
| +43.64% | 749B | |
| +39.42% | 605B | |
| -6.58% | 351B | |
| +19.72% | 328B | |
| +8.78% | 292B | |
| +11.92% | 216B | |
| -2.62% | 214B | |
| +6.13% | 165B | |
| +1.39% | 123B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.
